Impilo invests in Swedish HIV diagnostics company Cavidi

21 February 2018

Wigge & Partners has advised Nordic-based investment company Impilo on its investment in a 29% stake in Cavidi AB, an Uppsala-based diagnostics company focused on HIV Viral Load monitoring.

https://news.cision.com/impilo/r/impilo-invests-in-swedish-hiv-diagnostics-company-cavidi,c2456664

Team

Practice Areas

News & Transactions

02 June 2023

Wigge & Partners has represented the sellers in the sale of PropTech Sweden AB and its subsidiaries

19 April 2023

Wigge & Partners has advised MVI Fund I AB and Great Security Holding AB in connection with the acquisition of Vadsbolås and Vadsbolarm

28 March 2023

VIMAB Group AB (publ) acquires AoO CNC AB

17 February 2023

PodX Group acquires a majority stake in Filt as a step in their ambition to consolidate the international podcast market

27 January 2023

Disruptive Ventures and Fort Knox Förvaring initiate a collaboration to invest in growth companies in Umeå and Norrland

All News